Shows / Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Episodes
Decera Clinical Education Oncology PodcastCDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach
In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conjugates…
Decera Clinical Education Oncology PodcastTransforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for cutaneous…
Decera Clinical Education Oncology PodcastParoxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management
In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal…
Decera Clinical Education Oncology PodcastAdvancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative…
Decera Clinical Education Oncology PodcastAdvancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative…
Decera Clinical Education Oncology PodcastHER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with…
Decera Clinical Education Oncology PodcastKey Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of patients…
Decera Clinical Education Oncology PodcastPancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients
Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer…
Decera Clinical Education Oncology PodcastLatest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma…
Decera Clinical Education Oncology PodcastCDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions
In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CDK4/6…
Decera Clinical Education Oncology PodcastEmerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmonary…
Decera Clinical Education Oncology PodcastAvailable and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging…
Decera Clinical Education Oncology PodcastKey Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025
In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, explore the current and future implications of some of their top choices of studies in…
Decera Clinical Education Oncology PodcastExperts Discuss Key Studies in Breast Cancer: Independent Conference Coverage of the 2025 ASCO Annual Meeting
In this episode, Kevin Kalinsky, MD, MS, FASCO, and Sara M. Tolaney, MD, MPH, discuss the most clinically relevant data in breast cancer presented at the 2025…
Decera Clinical Education Oncology PodcastTakeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC
In this episode, listen to Laura M. Spring, MD; and Shipra Gandhi, MD, MS, share their takeaways from a large educational program on available and emerging…
Decera Clinical Education Oncology PodcastA New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
In this episode, Eunice Wang, MD and Eytan Stein, MD explore the latest key clinical updates on menin inhibitors in AML. This episode unpacks evolving…
Decera Clinical Education Oncology PodcastBTK Inhibitors in CLL: Key Clinical Updates From ASCO & EHA 2025
In this episode, James Davis, PharmD, BCOP and Victoria Nachar, PharmD, BCOP summarize the latest key clinical updates on BTK inhibitors in CLL based on data…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma
In this episode, Joseph W. Franses, MD, PhD; Neehar Parikh, MD, MS; and Mark Yarchoan, MD, share their thoughts on incorporating immune checkpoint inhibitors…
Decera Clinical Education Oncology PodcastPersonalized Pathways: Redefining Frontline Hodgkin Lymphoma Treatment Strategies
In this episode, Jonathan W. Friedberg, MD; Alex F. Herrera, MD; and Kara Kelly, MD, discuss the latest frontline treatment options for advanced Hodgkin…
Decera Clinical Education Oncology PodcastExperts Discuss CELMoDs in Myeloma
In this episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Sagar Lonial, MD, FACP, discuss key topics with CELMoD therapy for multiple myeloma…
Decera Clinical Education Oncology PodcastRole of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities
In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the…
Decera Clinical Education Oncology PodcastUncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, discuss the evolving safety…
Decera Clinical Education Oncology PodcastTaking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2-targeted…
Decera Clinical Education Oncology PodcastThe Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer
In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell…
Decera Clinical Education Oncology PodcastThe Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies
In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alterations…
Decera Clinical Education Oncology PodcastOncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC
In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current…
Decera Clinical Education Oncology PodcastExpert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions…
Decera Clinical Education Oncology PodcastBispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently…
Decera Clinical Education Oncology PodcastClinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a…
Decera Clinical Education Oncology PodcastRelapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific…
Decera Clinical Education Oncology PodcastGastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations
In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors…
Decera Clinical Education Oncology PodcastESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented…
Decera Clinical Education Oncology PodcastA Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for…
Decera Clinical Education Oncology PodcastAvailable and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and…
Decera Clinical Education Oncology PodcastAvailable Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline…
Decera Clinical Education Oncology PodcastROS1-Alterations and Molecular Testing in Advanced NSCLC
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in…
Decera Clinical Education Oncology PodcastMidyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for…
Decera Clinical Education Oncology PodcastNext-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the…
Decera Clinical Education Oncology PodcastCurrent Clinical Practice and NCCN Guidelines for CLL/SLL
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current…
Decera Clinical Education Oncology PodcastCongress to Clinic: Expert Takeaways on Emerging Data for MPNs
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the…
Decera Clinical Education Oncology PodcastCELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting…
Decera Clinical Education Oncology PodcastExperts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on…
Decera Clinical Education Oncology PodcastCongress to Clinic: Expert Takeaways on Emerging Data for AML
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at…
Decera Clinical Education Oncology PodcastCongress to Clinic: Expert Takeaways on Emerging Data for MDS
In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes…
Decera Clinical Education Oncology PodcastExperiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark…
Decera Clinical Education Oncology PodcastApplying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies…
Decera Clinical Education Oncology PodcastHomologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide…
Decera Clinical Education Oncology PodcastReal-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients…
Decera Clinical Education Oncology PodcastCurrent Considerations for Adverse Event Management With HER3-Directed Agents
The third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targeted…
Decera Clinical Education Oncology PodcastUnpacking the Potential of HER3-Targeted Therapy in NSCLC
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including: Recent data on…
Decera Clinical Education Oncology PodcastRecent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs. Presenters…
Decera Clinical Education Oncology PodcastExpert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 2023 IGCS…
Decera Clinical Education Oncology PodcastNovel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis…
Decera Clinical Education Oncology PodcastA Year in Review and a Look to the Future: BTKi in CLL and MCL
In this episode, Ana Marin-Niebla, MD, PhD, and Stephan Stilgenbauer, MD, discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the…
Decera Clinical Education Oncology PodcastExpert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
In this episode, Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, provide expert insights on new clinical trial data presented at the 2023 ESMO annual…
Decera Clinical Education Oncology PodcastExpert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
In this episode, Aakash Desai, MD; Narjust Florez, MD; and Paolo Tarantino, MD, discuss the biologic rationale and clinical development of agents targeting…
Decera Clinical Education Oncology PodcastImproving Care for Black Patients With Endometrial Cancer
In this episode, Dr Leslie Boyd and Adrienne Moore, a patient advocate and endometrial cancer survivor, discuss how healthcare professionals can partner with…
Decera Clinical Education Oncology PodcastExpert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on key updates and new clinical trial data presented at the…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at SOHO 2023 evaluating the use of BTK inhibitors in…
Decera Clinical Education Oncology PodcastNew Evidence With BTK Inhibitor Therapy in MCL From ICML 2023
In this episode, Catherine C. Coombs, MD, and Toby Eyre, MBChB, MD, discuss key trials presented at ICML 2023 evaluating the use of BTK inhibitors in mantle…